Tech meets Life Science!
Excited about innovation and about creating true impact in healthcare but don't have an idea to work on?
Nest Catalyst and 8200Bio are excited to invite you to join a unique opportunity to partner with scientists founders of newly emerging companies, in a joint tech-bio innovation program!
During the webinar you will have an opportunity to learn about the tech-bio joint innovation program and hear from the past cohort's participants.
To participate in the joint innovation program, successful applicants and the matched companies will work together on a short project during the month of May. What happens after the project is over? It is completely up to you and the founders!
As part of the joint innovation program you will also have an opportunity to join three Nest Catalyst online sessions related to entrepreneurship.
Presenting companies:
Jack Castelli and Norman f. Russkamp/ ECTx - ECTx is developing a non-toxic conditioning regimen that will make curative stem cell therapies accessible to the thousands of patients waiting.
Liat Rockah & Milit Marom / KickIN Bio - KickIN Bio is developing a Trojan RNA - silent in healthy cells, activated in tumors, and turning them into a drug factory that lasts until the cancer is gone.
Netanel Loyfer / EpiTrace Bio - The first ultra-sensitive platform for monitoring neuronal health and neuro-oncology through a simple blood draw
Diana Gataulin & Eyal Zoler / Virobix - Virobix is developing targeted gene-delivery platforms for localized cytokine therapy in hard-to-treat cancers. Our technology enables precise delivery and expression of potent immune modulators while reducing systemic exposure.
Nadav Wallis / RBPx - RBPx is developing AVJ16, a first-in-class oral small-molecule inhibitor of IGF2BP1, an oncofetal RNA-binding protein re-expressed in cancer but absent from healthy adult tissue. By disrupting oncogenic RNA stabilization, AVJ16 suppresses tumor growth and metastasis with a highly selective safety profile, establishing a new class of RNA-targeted cancer therapeutics.
Cristabelle De Souza / Resilion Therapeutics - Resilion Therapeutics utilizes a proprietary AI platform to engineer first-in-class, antigen- recycling antibodies designed to overcome drug resistance in solid tumors
Nest Catalyst - For Scientists, by Scientists. Nest Catalyst is an entrepreneurship program tailored for early-stage life science ventures. Learn from world-class experts in R&D, business, product development, marketing, fundraising, and more.
8200 Bio is a non-profit organization dedicated to empowering the transformation of Israel into a Health-tech Nation by building a flagship of 8200alumni. 8200 Bio, a part of the 8200 Alumni Association, helps 8200 alumni to make the most out of this transformation by providing meaningful networking and professional opportunities, and facilitating collaboration.
By registering for this event, you agree to release Nest Catalyst Ventures from all liability related to your participation in the event. You also consent to be subscribed to the Nest Catalyst newsletter for updates and future events. You also consent that your contact details will be shared with our sponsors. You may unsubscribe at any time.